-
BioCorRx Provides Business Update for the Third Quarter of 2020; BioCorRx Subsidiary, BioCorRx Pharmaceuticals Inc. Progressing with Pivotal Nonclinical BICX102 Study
[ad_1] Announces Promotion of Lourdes Felix to CEO; Brady Granier to Serve as President Anaheim, CA – (NewMediaWire) – November…
Read More » -
One-month of dual anti-platelet therapy is safe and feasible after stent placement
[ad_1] Research Highlights: A short, one-month treatment combining antiplatelet medication and aspirin followed by an aspirin-only regime was as effective…
Read More » -
Omega-3s did not reduce cardiac events in recent heart attack survivors
[ad_1] Research Highlights Omega-3 supplements in commonly available forms appear to be ineffective in preventing further cardiovascular events among elderly…
Read More » -
News
Side effects often attributed to statins were the same for those taking a placebo
[ad_1] Research Highlights: Study participants who reported side effects from cholesterol-lowering medications known as statins also reported the same side…
Read More » -
Ticagrelor was not superior to clopidogrel to reduce heart attack risk during angioplasty
[ad_1] Research Highlights: A new study found the rate of heart attack and severe complications before, during or soon after…
Read More »